FDA Inspection 1028730 — Kopalle Pharma Chemicals Pvt Ltd.
The FDA completed an inspection of Kopalle Pharma Chemicals Pvt Ltd. on October 13, 2017 in Hyderabad. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 13, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hyderabad (India)